Vilim Molnar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Knee Osteoarthritis

Hyaluronic Acid

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Smojver Igor, Ivan Katalinić, Roko Bjelica, Dragana Gabrić, Vid Matišić, Vilim Molnar, Dragan Primorac
Mesenchymal Stem Cells Based Treatment in Dental Medicine: A Narrative Review. International journal of molecular sciences 23 (3) (2022)
Vilim Molnar, Eduard Stjepan Pavelić, Kristijan Vrdoljak, Martin Čemerin, Emil Klarić, Vid Matišić, Roko Bjelica, Petar Brlek, Ivana Kovačić, Carlo Tremolada, Dragan Primorac
Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. Genes 13 (6) (2022)
Dragan Primorac, Petar Brlek, Vid Matišić, Vilim Molnar, Kristijan Vrdoljak, Renata Zadro, Marijo Parčina
Cellular Immunity-The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination. Vaccines 10 (3) (2022)
Dragan Primorac, Vilim Molnar, Vid Matišić, Damir Hudetz, Željko Jeleč, Eduard Rod, Fabijan Čukelj, Dinko Vidović, Trpimir Vrdoljak, Borut Dobričić, Darko Antičević, Martina Smolić, Mladen Miškulin, Damir Ćaćić, Igor Borić
Comprehensive Review of Knee Osteoarthritis Pharmacological Treatment and the Latest Professional Societies' Guidelines. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics 13 (9) (2021)
Dragan Primorac, Vilim Molnar, Eduard Rod, Željko Jeleč, Fabijan Čukelj, Vid Matišić, Trpimir Vrdoljak, Damir Hudetz, Hana Hajsok, Igor Borić
Knee Osteoarthritis: A Review of Pathogenesis and State-Of-The-Art Non-Operative Therapeutic Considerations. Genes 11 (8) (2020)